U.S. Markets closed

House Passes Pelosi’s Sweeping Drug Bill

The Fiscal Times Staff

A bill backed by Speaker Nancy Pelosi that would empower the federal government to negotiate lower drug prices passed the House Thursday in a 230-192 vote, largely along party lines.

As we told you yesterday, the bill is not expected to become law, but it will provide Democrats with a talking point on an issue voters say is important to them in the 2020 election.

Democratic candidates are expected to highlight their effort to lower drug prices in the bill, in contrast to President Trump’s backing away from his pledge to allow Medicare to “negotiate like crazy” with drugmakers.

For more on the bill, see The Hill, The Washington Post and CBS News.

Like what you're reading? Sign up for our free newsletter.